Rabbit
Rabbit Dacryocystitis: Clinical Workup and Treatment Planning
Bottom line
Rabbit dacryocystitis is a localization problem before it is an antimicrobial problem. Confirm that discharge originates from the lacrimal drainage system, assess the ocular surface, investigate dental and nasal disease, and distinguish a patent but inflamed duct from partial or fixed obstruction. Chronic inflammation can narrow the punctum or duct through scarring until obstruction is irreversible, and traumatic flushing can itself produce permanent epiphora.[1]
Presentation and localization
Typical presentations include unilateral or bilateral epiphora, mucous or purulent material at the medial canthus or punctum, wet facial fur, periocular dermatitis, and recurrent conjunctivitis. Pain, blepharospasm, corneal opacity, exophthalmos, facial swelling, nasal discharge, reduced appetite, or weight loss should widen the problem list beyond uncomplicated drainage disease.
Start by identifying the source of fluid. Discharge refluxing through the punctum or expressed during gentle lacrimal-sac manipulation supports dacryocystitis, whereas diffuse conjunctival hyperemia without punctal material may reflect primary conjunctival or surface disease. Epiphora alone can result from excess tear production, impaired drainage, eyelid disease, corneal pain, or obstruction. A fluorescein passage test can show that dye reaches the nares, but failure to see nasal dye does not by itself define the site or cause of obstruction.
Perform a complete ophthalmic examination before instrumentation: eyelids, conjunctiva, punctum, cornea, anterior chamber, globe position, and, when possible, fundus. Stain the cornea before assuming discharge is the primary lesion. Palpate the maxilla and mandible, assess nasal airflow and discharge, and complete a rabbit dental disease and malocclusion workup under appropriate sedation or anesthesia when an awake oral examination is incomplete.
A 2009 retrospective series included 28 rabbits referred with nasolacrimal-duct discharge. Within that selected cohort, 25 rabbits (89%) had unilateral dacryocystitis, dental malocclusion was recorded in 14 (50%), and no underlying cause was determined in 10 (35%).[2] These are case-series findings, not population prevalence or proof that malocclusion caused every affected eye.
Build the diagnostic plan
The initial plan should answer four questions: Is the globe or cornea threatened? Is the drainage pathway patent? Is infection present at the affected site? Is dental, nasal, periocular, or orbital disease driving the process?
A practical sequence is:
- Document laterality, discharge character, pain, globe position, appetite, fecal output, body weight, and previous treatment response.
- Complete ophthalmic and oral examinations, including fluorescein staining and careful assessment of the punctum.
- Collect an indicated sample before lavage or new antimicrobials when a meaningful specimen can be obtained.
- Attempt gentle nasolacrimal cannulation and flushing only with suitable restraint, analgesia, equipment, and a plan to stop if resistance is encountered.
- Add skull imaging when dental disease, fixed obstruction, recurrence, facial asymmetry, exophthalmos, rhinitis, or deeper infection is suspected.
In the 28-rabbit series, clinicians flushed 27 of 31 affected eyes (87%).[2] That figure describes what was done in one retrospective referral cohort; it does not establish flushing as mandatory or successful in every case. Record whether fluid passes to the nose, refluxes around the cannula, exits the opposite punctum, carries debris, or cannot be advanced. Forceful pressure risks creating a false passage or damaging a fragile duct.[1]
Sampling without overcalling infection
Sample selection depends on the question. Superficial conjunctival material is easy to obtain but may not represent the lacrimal sac or a deeper obstructed segment. When safe and technically feasible, material obtained from punctal reflux or an initial duct sample before lavage is more anatomically relevant. Request cytology and aerobic culture with susceptibility testing; add anaerobic or other targeted testing when lesion character and laboratory handling support it.
Interpret culture alongside cytology, sampling site, prior antimicrobial exposure, imaging, and clinical inflammation. Merck notes that Pasteurella can be sampled from clinically normal rabbits and that culture results require interpretation with clinical signs and susceptibility data.[1] Use the broader rabbit pasteurellosis treatment framework when respiratory or multisite disease is present. A positive result therefore identifies recoverable organisms; it does not, alone, prove that the isolate created the obstruction or explains all disease. Conversely, a negative culture after prior therapy or from a low-yield specimen does not exclude a focal infected site.
Imaging and the search for a driver
Survey skull radiographs may identify advanced dental or osseous change, but superimposition can obscure early or focal lesions. Cross-sectional imaging is preferred when results will change dental, surgical, or prognostic decisions. Evaluate tooth crowns and reserve crowns, apices, surrounding bone, nasal cavity, nasolacrimal course, orbit, and adjacent soft tissue rather than reading the duct in isolation.
Contrast dacryocystorhinography can outline the drainage pathway and localize an obstruction; Merck describes injection of contrast through the punctum as providing radiographic detail of the duct and obstruction site.[1] Use it as an anatomic study, not as proof of bacterial causation. CT with or without contrast dacryocystography may better define concurrent dental, nasal, orbital, or bony disease when available.
The association with other disease must remain cohort-scoped. In a 2015–2018 retrospective review at one UK first-opinion/referral exotics clinic, dacryocystitis was identified in 55 of 821 examined rabbits (6.70%). Among rabbits classified with dacryocystitis, the authors recorded dental disease in 24 (45%), respiratory disease in 20 (38%), aural disease in seven (13%), and concurrent ocular disorders in 15 (23%).[3] Those record-based categories may overlap and should not be treated as mutually exclusive causes. The same study identified Lionhead/Lionhead cross and Dwarf Lop/Dwarf Lop cross status as risk factors within that clinic population.[3]
Treatment planning and monitoring
Match treatment to anatomy and severity. A patent duct with inflammatory debris may benefit from carefully performed lavage and locally directed therapy. Purulent material, cytologic inflammation, or a clinically relevant isolate may justify antimicrobial treatment selected for the rabbit, site, and susceptibility result. Avoid assuming that a topical drug will reach a closed segment or that systemic treatment will correct a mechanical obstruction.
Address the driver whenever possible: dental treatment for relevant apical or periodontal disease, management of rhinitis, removal of accessible foreign material, protection of an ulcerated cornea, and care of periocular skin. Use a species-appropriate rabbit analgesia plan; hydration, nutritional support, and gastrointestinal monitoring may be as important as local therapy in a painful or anorectic rabbit.
Fixed stenosis, mineralization, an inaccessible obstructive focus, or extensive dental or orbital disease may make cure unrealistic. Discuss whether the goal is restoration of patency, control of infection and discomfort, periodic management of recurrent discharge, or palliation. Surgical options require case-specific imaging and expertise; repeated blind or forceful instrumentation is not a substitute for defining the lesion.
Recheck the cornea, discharge, pain, facial skin, appetite, weight, and duct findings. A temporary reduction in discharge does not prove that the underlying lesion has resolved. Recurrence should trigger reassessment of sampling quality, patency, dental and nasal imaging, owner administration, and the original diagnosis rather than automatic repetition of the same protocol.
Frequently Asked Questions
Does every rabbit with epiphora have dacryocystitis? No. Epiphora can reflect excess tear production, corneal pain, eyelid disease, conjunctival inflammation, impaired drainage, or obstruction. Localize the discharge and complete the ocular examination before labeling the case.
Does a positive culture prove the organism caused the obstruction? No. It proves that the sampled material contained recoverable organisms. Interpret the result with specimen site, cytology, prior therapy, susceptibility, imaging, and evidence of inflammation.
Should every affected duct be flushed? No. Flushing can be diagnostic and therapeutic, but the decision depends on ocular integrity, restraint or anesthesia safety, duct anatomy, and resistance during cannulation. Stop rather than forcing a nonpatent pathway.
When is CT imaging indicated for rabbit dacryocystitis? CT is most useful for recurrent disease, suspected dental or nasal involvement, fixed obstruction, exophthalmos, facial asymmetry, deep infection, or cases in which defining lesion extent will change treatment or prognosis.
Can dental disease be assumed from ocular discharge? No. Dental disease is an important differential and should be actively investigated, but some affected rabbits have no identified underlying cause. The Florin et al. 28-rabbit series recorded dental malocclusion in 14 rabbits and no determined cause in 10.
Why can dacryocystitis recur after apparent improvement? Inflammation may persist behind a narrowed segment, a mechanical or dental driver may remain, scar tissue may limit drainage, or therapy may have reduced discharge without restoring patency. Recurrence warrants relocalization and renewed cause assessment.
What should be monitored after treatment begins? Track discharge, comfort, corneal integrity, periocular skin, appetite, fecal output, body weight, nasal signs, and the ability of tears or lavage fluid to pass. Escalate promptly for globe pain, corneal change, exophthalmos, facial swelling, anorexia, or systemic decline.
References
Voyage Dispatch · thevoyage.ai/forvets/knowledge/rabbit-dacryocystitis-clinical-workup · published Aug 19, 2026 · verify dosing against the current formulary before prescribing
More clinical updates
Rabbit Dental Disease and Malocclusion: A Clinical Reference for Veterinarians
A DVM clinical reference on rabbit acquired dental disease and malocclusion: dental anatomy, the fiber- and calcium-driven pathophysiology, imaging, coronal reduction and incisor extraction, tooth-root abscess surgery, meloxicam analgesia, and lifelong management.
Read →Rabbit Pasteurellosis (Snuffles): Antibiotic Selection & Treatment
DVM reference for Pasteurella multocida in rabbits: which antibiotics are rabbit-safe (enrofloxacin, TMS, chloramphenicol, azithromycin, parenteral penicillin G) versus the oral penicillins, clindamycin, and lincomycin that cause fatal enterotoxemia. Culture, clinical spectrum, and prognosis.
Read →Rabbit Analgesia and Pain Management: Evidence-Based Dosing
Evidence-based rabbit analgesia for DVMs: why meloxicam is dosed at 1 mg/kg, buprenorphine route matters (IV/IM over SC), opioid GI-motility ranking, local blocks and CRIs, multimodal protocols, and objective pain scoring with the Rabbit Grimace Scale and RPBS.
Read →Rabbit Thymoma: Diagnosis and Treatment Planning
A clinician-focused approach to respiratory stabilization, imaging and sampling of cranial mediastinal masses, and evidence-limited decisions among surgery, radiation therapy, and palliation in rabbits with suspected thymoma.
Read →